What's new in the field of prostate cancer chemoprevention?
Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.
Mahal
Kanwaljit
K
Division of Urology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Hernandez
Javier
J
Basler
Joseph W
JW
Thompson
Ian M
IM
D000975:Antioxidants / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods / Q000639:trends*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D012643:Selenium / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D016861:Cyclooxygenase Inhibitors; D014810:Vitamin E; D012643:Selenium